PyInvesting

Market research

OSE.PA OSE Immunotherapeutics SA

PA EUR Healthcare

Latest close

1.521 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
43M
P/E ratio
Not available
Analyst target
11.875
Dividend yield
Not available
Beta
1.05

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

OSE Immunotherapeutics SA is currently in a long term uptrend where the price is trading 6.8% above its 200 day moving average.

From a valuation standpoint, the stock is 95.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 12.1.

Finally, its free cash flow fell by 119.5% to $-5M since the same quarter in the previous year.

Based on the above factors, OSE Immunotherapeutics SA gets an overall score of 2/5.